By: Ashling Wahner From: onclive.com As the treatment of HER2 in breast cancer becomes better defined, the HER2-directed antibody trastuzumab (Herceptin) has earned a place as a standard agent in several stages of HER2-positive disease, and additional HER2-targeted drugs may build on historical treatment successes achieved with this agent, according to Debu Tripathy, MD. “The early studies of trastuzumab in …
Social determinants of health must be addressed to improve patient outcomes
From: sabcsmeetingnews.org The community where a person lives has a significant impact on that individual’s health outcomes. “In many cases now, people are wondering if your ZIP code is almost as important as your genetic code because where you live, work, and play truly can impact your health,” said Amelie G. Ramirez, DrPH, MPH, UT Health Science Center at San …
Targeted diet and exercise intervention could improve chemotherapy outcomes for breast cancer patients
Source: Yale School of Medicine From: news-medical.net A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer. Finishing chemotherapy is crucial for improving breast cancer treatment odds, but many patients with breast cancer do not follow their full treatment plan because of the side effects that come …
Expert Highlights Precision Medicine in Breast Cancer During Breast Cancer Awareness Month
By: Danielle Ternyila From: targetedonc.com Most patients with breast cancer are curable, according to Hannah Linden, MD, and by identifying patients with mutations, targeted therapies can be used to help improve outcomes and survival in many patients. “We are doing better for helping women with breast cancer, and it’s a more treatable disease,” said Linden. “Imaging, liquid biopsy, and molecular …